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Abstract: Vector-borne infectious diseases are emerging or resurging as a result of changes in public health policy, demographic and
societal changes, insecticide and drug resistance, shift in emphasis from prevention to emergency response, genetic changes in
pathogens in the last two decades of the twentieth century. Climate changes also can influence the emergence and reemergence of
these diseases which are malaria, dengue, yellow fever, plague, filariasis, louse-borne typhus, lyme disease, trypanosomiasis,
leishmaniasis and viral diseases. West Nile virus is just the latest example of this type of invasion by exotic virus. This paper will
provide an overview of the distribution, reasons of emergence or reemergence of the important vector-borne diseases throughout
the world.
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Çevre De¤ifliklikleri ile Ortaya Ç›kan Vektör-Kökenli Hastal›klar
Özet: Vektör kökenli infeksiyon hastal›klar›, 20. yüzy›l›n son y›llar›nda halk sa¤l›¤› politikalar›ndaki de¤ifliklikler, demografik ve sosyal
de¤ifliklikler, insektisit ve ilaç direnci, koruma yöntemlerinden acil tedavi yöntemlerine kay›fl ve patojendeki genetik de¤ifliklikler
nedeniyle yeniden önem kazanmaya bafllam›flt›r. ‹klimsel de¤ifliklikler de, malaria, deng, sar› humma, veba, filariasis, bit ile bulaflan
tifus, lyme hastal›¤›, trypanosomiyasis, leiflmaniyasis ve viral hastal›klar gibi vektör kökenli hastal›klar›n yeniden ortaya ç›k›fl›nda etkili
olabilir. Bat› Nil virusu, ekzotik viruslar›n yay›l›m›na ait son örnektir. Bu makalede, önemli vektör kökenli hastal›klar›n da¤›l›m›,
yeniden ortaya ç›k›fllar›n›n nedenleri global olarak özetlenmeye çal›fl›lm›flt›r.
Anahtar Sözcükler: Vektör-Kökenli hastal›klar, Malarya, Sar› humma, Deng hummas›, Veba, Lyme hastal›¤›, Tifus, Arboviruslar,
Bat› Nil virusu

During the history of human cultural evolution,
population dispersal around the world and subsequent
inter-population contact and conflict there have been
several distinct transitions in the relationships of Homo
sapiens with the natural world. Each of these transitions
in human ecology and in inter-population interaction has
profoundly changed the patterns of infectious disease. In
the first transition, human settlements allowed countless
novel strains of bacteria and viruses to make the jump
from domesticated herds of naturally gregarious animals
to humans (1).
Anthropological research in Africa has shown that
malaria-protective sickle-cell trait arose when iron tools
and slash-and-burn agriculture were introduced,
presumably by creating new breeding sites for Anopheles
gambiae, the major mosquito vector for falciparum
malaria (1, 2).

The second great transition occurred from around
2500 to 1000 years BC with travel and military
movements between the contiguous land masses of
Europe, northern Africa and Asia. And the third great
transition began around five centuries ago and entailed
the trans-oceanic spread of disease.
These three great historical transitions were
processes of equilibration between first humans and
animal species and later, among regional human
populations. As new ecological niches were created by
changes in human cultural practices, microbes exploited
those niches. As new contacts were made between
previously isolated civilizations, infectious diseases were
shared. In today’s globalizing world, populations
everywhere are becoming interconnected economically,
culturally and physically, enhancing the mixing of people,
animals, and microbes from all geographical areas
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McMichael asks “Are we experiencing history’s fourth
transition? “at this moment (1).
In today’s world, no country is safe from infectious
diseases (3). Human mobility has escalated dramatically in
volume and speed between and within countries. Longdistance trade facilitates the geographical redistribution
of pests and pathogens. In this review article, changing
social, cultural and environmental conditions have been
related to the new distribution pattern of the diseases,
emphasizing vectorial-diseases, to clarify the above
question.
Historically, vector-borne diseases such as malaria,
dengue, yellow fever, plague, filariasis, louse-borne
typhus, trypanosomiasis, and leishmaniasis were
th
responsible for more human disease and death in the 17
th
through the early 20 centuries than all other causes
combined (4). After successful control programs by the
1960s, vector-borne diseases were no longer considered
major public health problems outside Africa. However,
the benefits of vector-borne disease control programs
were short-lived, and in the last thirty years, there has
been a dramatic global resurgence of infectious diseases.
Some important diseases were recognized for the first
time, including HIV/AIDS, hantavirus pulmonary
syndrome, Ebola, Lyme disease and ehrlichiosis. Equally
important was the rising incidence of many recognized
diseases that had been effectively controlled since 1960s
(1,4-6). New combinations of diseases have also been
noted, such as the appearance and spread of co-infections
of HIV virus and leishmaniasis (7). By 2004, vector-borne
diseases like malaria and dengue hemorrhagic fever are
among the most serious public health problems in
countries where there are no properly-trained vector
biologists in the Ministries of Health (5,7,8).
Although the reasons behind this dramatic resurgence
of arboviral diseases are complex, Gubler (2002) listed
the following factors:
Demographic changes including global population
growth, population movements, and unplanned and
uncontrolled urbanization;
Societal changes such as human encroachment on
natural disease foci, modern transportation,
containerized shipping;
Agricultural changes including changes in land use,
irrigation systems, deforestation;
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Changes in pathogens due to increased movement in
humans and animals and genetic changes leading to
increased epidemic potential;
Changes in public health including lack of effective
vector control, deterioration of public health
infrastructure to deal with vector-borne diseases, disease
surveillance and prevention programs and possible
climate change (9).
It is clear that certain demographic and societal
changes in the past 30 years have had a major impact on
the ecology of vectorial diseases. Modern transportation
ensures faster and increased movement of humans,
animals, and commodities and their pathogens between
regions and population centers of the world. For
example, in the past twenty years, four exotic mosquito
species have been introduced and established in the
United States; three of these are potential vectors of local
diseases (5,10). Aedes albopictus (Asian tiger mosquito)
of Asian origin, first spread to the America and African
continents, and is now established in North and South
America, Africa, Oceania and Europe. It was first detected
in Europe in 1979 in Albania, after which it has been
reported from many different countries (7,11-19). By
late 2001, Ae. albopictus had rapidly become the most
important pest species in northern Italy. In 1996, another
introduced mosquito species Aedes atropalpus was
discovered the Ventao region of northern Italy. More
recently, Ochlerotatus japonicus, an Asian mosquito, has
been reported from Normandy, France where it was
found breeding in tires, like the above Aedes species (12).
The establishment of exotic mosquitoes in Australia and
New Zeland was viewed as a serious concern by health
authorities of both countries (10).
To consider other vector species, the tick, Dipteran
larva, cockroach species have been recorded as
introduced species as well. There is an increasing trend of
Tick-borne encephalitis cases in Europe, partly due to
changes in human behaviour that bring more people into
contact with infected ticks. Increasing trends in mean
temperature values also effects the distribution of many
tick species in Northern Europe. Dipteran larvae, a cause
of myiasis, are often found or travelers returning from
tropical countries. Cockroaches are ubiquitous pest
aboard ships and aircraft, and exotic species are quite
often transferred from one country to another (7). The
high rates of transmission by different vectors to
different vertebrate hosts in new geographic areas can

N. ÖZER

result in selective pressures that lead to genetic changes
in the pathogen. These new strains of virus may have
greater epidemic potential and virulence. For example,
the unique susceptibility of young domestic geese in Israel
in 1997-2000 to West Nile virus and the isolation of
similar strains from migrating White storks in Israel and
Egypt suggest that the recent isolates are more
pathogenic for certain avian species (20).
Deforestation provides new ecological niches and
conditions for proliferation of newly arriving and/or
adaptive vectors and their parasites. The replacement of
forests with crop farming, ranching and raising small
animals can create a supportive habitat for parasites and
their host vectors. New settlers to a deforested area are
particularly vulnerable as they lack immunity to the
zoonotic parasites endemic to the area. In adapting to
changed environmental conditions, including reduction of
non-human population and increased human population,
some vectors display a conversion from a primarily
zoophyllic (bites to animal) to primarily anthrophophilic
(bites to human) orientation. Water control projects can
create new breeding habitats for mosquitoes, snails, their
larvae and their parasites. The construction of new roads
provides access for new human, livestock, vector and
parasite populations (21).
Let us see how climate can be effective on vectorborne diseases. The International Council of Scientific
Unions Intergovernmental Panel of Climate change,
established by the World Meteorological Organization and
the United Nations Environmental Program, have
estimated that by the year 2100, average global
temperatures will have risen by between 1.0oC to 3.5 oC.
Important ecological changes may come about in the
future due to this global warming. The distribution and
seasonality of diseases that are transmitted by coldblooded insects or ticks are likely to be affected by climate
change (7,21-23). Even if there are no certain data that
confirm that changes in climate have been responsible for
the recent resurgence of vector-borne diseases, there are
many studies on this subject.
The incidence of mosquito-borne diseases, including
malaria, dengue, and viral encephalitis are among those
diseases most sensitive to climate (21,24-27). Climate
change would directly affect the transmission of the
diseases by shifting the vector’s geographic range and
increasing reproductive and biting rates and by
shortening the pathogen incubation period. Human

susceptibility to infections might be further compounded
by malnutrition due to crop failure caused by climate
stress (21). Temperature can affect both the distribution
of the vector and the effectiveness of pathogen
transmission through the vector. In more detail
temperature can affect survival of the vector, the rate of
vector population growth, feeding behavior, susceptibility
of the vector to pathogens, incubation period of the
pathogen, seasonality of vector activity, and the
seasonality of pathogen transmission. For example, the
relation between El-Nino events and increased malaria
risk is partly due to increased temperature and partly due
to increased rainfall leading to increased mosquito
breeding sites because of surface water collections
(7,28). As another example, decreased rainfall has been
shown to be associated with epidemics of SLE (St Louis
encephalitis) when the vector Culex pipiens breeds
effectively in urban drainage systems (21). Unusual
abundance of some vectors, such as ticks or changed
behavior of other pests, such as higher anthropophily of
Cx. pipiens may in some areas be attributed to climate
changes in Europe (29).
The northern range of the occurrences of endemic
malaria has been estimated to coincide with a summer
o
isotherm of 16 C. However, even a superficial
examination shows that malaria also occurred in the
northern parts of Sweden and Finland, where the
summer temperature was considerably below 16 oC
(30,31). Climatic factors that increase the inoculation
rate of Plasmodium parasites, as well as the breeding
activity of Anopheles mosquitoes, are considered the
most important cause of epidemic outbreaks of malaria in
nonendemic areas. According to malaria models under
climate change scenarios, the risk of malaria epidemics
would rise substantially in both tropical and temperate
regions (28). In a MS thesis carried out in southern
Turkey, the correlation between climatic parameters and
changes in the number of malaria cases up to present was
evaluated by using GIS and it was noted that these
changes have a positive effect on the survival of
Anopheles sacharovi Favre and Plasmodium vivax (32).
Malaria is the most important tropical diseases with
more than half of the world’s population living in areas of
risk and with an estimated 200 million cases and two
million deaths each year (3,7,33-35). It has been on the
rise in many parts of Africa, with the mortality in young
children almost doubling from the 1980’s to the 1990s.
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The disease causes some 3000 deaths each day and
imposes huge losses in economic productivity (36).
Widespread drug resistance in the parasites and insecticide
resistance among anopheline mosquito vectors have
complicated malaria control. Malaria is also the most
common imported disease in the United States, where
Anopheline mosquito vectors still exist (35). Until after
the end of World War II, malaria was endemic throughout
much of southern Europe. The Balkans, Italy, Greece and
Portugal were particularly affected, although seasonal
epidemics or outbreaks occurred as far north as
Scandinavia, Finland, Norway and southern Sweden. The
area of malaria distribution in Europe peaked at the
beginning of the twentieth century. Soon after the war,
intensive control measures were initiated and by 1970 the
WHO declared malaria eradicated from Europe. However,
populations of potential Anopheles vectors of malaria
remain high in many countries of the continent and their
presence posses the risk of renewed transmission (7,3739). The WHO Regional Office for Europe reported a total
of 15,528 cases of imported malaria in Europe in the year
2000 (7). Local transmission has also frequently occurred
in Europe in the form of airport malaria. This refers to the
transmission of malaria as a result of the inadvertent
transport of live, malaria-infected mosquitoes aboard
aircraft arriving from tropical malaria-endemic countries
(6,40). The most serious problem of resurgent malaria is
in the newly independent states (Azerbaıjan, Tajikistan)
and in Turkey; due to an influx of refugees from malaria
endemic areas, the breakdown in health services, and the
lack of vector control measures in most of these states, as
well as in the failure to carry out adequate malaria
surveillance and control measures (7). In Turkey, the
mosquito species have been revised (41,42) and the
malaria vectors, population dynamics and control
strategies have been determined in some recent studies
(43-48). According to these studies, Malaria epidemics
had been seen twice in 20 years in Sanlıurfa where is in
the heart of the GAP (Southeastern of Anatolian Project)
project area. Earlier malaria was most frequent in
Çukurova and its provinces but nowadays it is most
frequent in Southeastern Anatolian region, partly because
of the migration and the changing environmental
conditions due to irrigation project.
Leishmaniasis, which comes next after malaria in
importance, is a protozoon disease in which clinical
manifestations are dependent both on the infecting
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species of Leishmania and the immune response of the
host. Leishmaniasis and its sandfly vectors are found in
some 88 countries, mainly in tropical and sub-tropical
areas, is also widespread in southern Europe (49). The
overall prevalence of Leishmaniasis is 12 million cases
worldwide, and the annual global incidence of all clinical
forms approaches 2 million new cases. Clearly human and
canine leishmaniasis is a serious problem in southern
Europe, with infection showing a rising trend, especially
leishmania/ HIV co-infection cases (7). A total of 14
Phlebotomus species have been identified from Turkey
(50-55). More recent studies have insisted on the
changing environmental conditions due to new water
regimes and agricultural practices and the increasing
numbers of the human cutaneous leishmaniasis cases
have been observed (48,56-58).
Historically, African sleeping sickness transmitted by
the tsetse fly, has been a major impediment to the social
and economic development of Central and East Africa. In
the past 20 years, major epidemics have occurred in East
and Central Africa, mainly because control programs
were disrupted by war (35).
Tick-borne diseases are also sensitive to climatic
conditions but favor cooler temperatures (26). Lingren
stated that, the distribution of tick vectors in Sweden has
expanded northward between 1980 and 1994,
consistent with observed changes in climate. Documented
increases in the incidence of Tick-borne encephalitides
over the last decades have been reported from many
countries in Europe, as the result of increased densities of
vector tick species (7).
Lyme Disease, transmitted by Ixodes scapularis or
pacificus ticks is caused by Borrelia burgdorferi.
Discovered in the United States in 1975, the disease has
continued to increase in incidence and geographic
distribution since national surveillance was initiated in
1982 (7). It is the most commonly reported vector-borne
disease in Europe and North America; its incidence is
clearly increasing, and new species of Borrelia are
continuously being found. Among the reasons for this
increase are ecological changes such as reforestation that
favour greater densities of tick vector populations and
increased exposure of persons to tick bites when visiting
endemic areas (7). The Swedish study indicated that the
reported northern shift in the distribution limits of ticks
was related to fewer days during the winter seasons with
o
low minimum temperatures below – 12 C (59).
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Plague, is the original emerging disease, having
caused major pandemics. Like many other vector-borne
diseases, plague was controlled with antibiotics,
insecticides and rat control in the latter half of the 20th
century. In recent years, however, epidemic plague has
resurged, most notably in Africa, with an average of
nearly 3,000 cases reported annually (35).
Onchocerciasis or “river blindness” vector requires
fast-flowing water for succesfull reproduction and the
adult vector can be spread by wind. According to the
increased temperature and precipitation levels, black fly
populations may increase by as much as 25 % at their
current breeding sites (21).
Among other vector-borne diseases affected by
climate changes, Schistosomiasis has increased in
prevalence in arid warm regions primarily from expansion
of irrigation systems where snails serve as the
intermediate host (28).
Viral diseases transmitted by blood-feeding
arthropods (arboviral diseases) are among the most
important of the emerging infectious diseases public
health problems facing the world at the beginning of the
third millennium (5,60-63). These include Dengue,
Dengue haemorhagic fever, Yellow Fever, Japanese
Encephalitis, West Nile Fever, Kyasanur Forest disease,
Venezuelan equine encephalitis, Epidemic polyarthritis,
Barmah forest and Mayaro Rift Valley Fever, Oropouche,
and Crimenean-Congo hemorrhagic fever (5,35). There
are currently 534 viruses registered in the International
Catalogue of Arboviruses, of which 40 % are known or
probable arboviruses; 25 % have caused documented
illness (5). Although some arboviruses that cause human
disease such as Barmah Forest disease in Australia have
been newly recognized, the greatest problem is by far the
viruses mentioned above. Arboviruses have a worldwide
distribution. But, in the last two decades, the geographic
distribution of both vectors and viruses has expanded
globally. The geographic distribution of each arbovirus is
restricted by the ecological parameters governing its
transmission cycle. These cycles are usually silent and
undetected in nature until some environmental change
allows the virus to escape the primary cycle via a
secondary vector or vertebrate host, or when humans
invade or encroach on the nidus of infection. Mosquitoes
are by far the most important vectors of arboviruses, and
birds and rodents are the most important vertebrate
reservoir hosts. These zoonotic viruses circulate in nature

either in an Aedes-mammal, Anopheles-mammal or
Culex-bird transmission cycles (64,65).
The Dengue viruses are the most widespread
geographically of the arboviruses and are found in
tropical and subtropical areas where 2.5-3 billion people
are at risk of infection with 50-100 million cases of
Dengue fever and 500.000 cases of DHF. It is an old
disease that distributed worldwide in the tropics during
the 18th and 19th centuries when the shipping industry
and commerce were expanding. Both the principal
mosquito vector, Aedes aegypti and the viruses
responsible for Dengue fever were spread via sailing
ships. In those times because of the slow mode of
transportation, epidemics were infrequent with intervals
of 10-40 years. The global epidemiology and
transmission dynamics of dengue viruses were changed in
Southeast Asia during World War II. Today, dengue fever
causes more illness and death than any other arbovirus
disease of human (9,35,66-69). New dengue virus
strains and serotypes will likely continue to move
between areas where A. aegypti occurs in infected air
travelers, resulting in increased frequency of epidemic
activity and increased incidence of Dengue haemorhagic
fever (70). Although funding for dengue vaccine
development has been sparse, good progress has been
made over the past ten years (9,71).
Currently, Dengue viruses are being transmitted in the
tropics between 30o north and 20o south latitude, since
frosts or sustained cold weather kills adult mosquitoes
and overwintering eggs and larvae. Warming trends,
therefore can shift vector or disease distribution to higher
latitudes or altitudes as was observed in Mexico when
dengue reached an altitude of 1700m during the
unseasonably warm summer in 1998. Temperature also
affects the transmission dynamics of dengue, because
warmer temperatures reduce the size of Ae .aegypti
individuals, smaller adults must feed more frequently to
develop egg batches, resulting in double feeding (28).
West Nile virus is the latest example of invasion by
exotic viruses. West Nile virus was first isolated in 1937
from the blood of a febril patient in the West Nile district
of Northern Uganda. During 1994-2000, epidemics of
WNV meningoencephalitis occurred at a new alarming
rate in North Africa, Europe, North America and the
Middle East (72,73).
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Yellow fever is an old, well-known disease that caused
major epidemics in the Americas and in Africa from 17th
to 20th centuries. Like Dengue and DHF, these were
primarily urban epidemics transmitted by Ae. aegypti (9).
West Nile virus was first detected in the United States
in September 1999 during the investigation of an
outbreak of encephalitis in humans in New York City (7480). The dramatic appearance of epidemic
meningoencephalitis in New York City in 1999 is an
unsettling reminder of the ability of viruses, including
arboviruses, to jump continents and hemispheres. WNV
rapidly spread across the United States and invaded
California during 2003 (81). The continued movement
west into large population centers in California increases
the urgency of continued efforts to develop intervention
methods (73). WNV is mainly transmitted by Culex
mosquitoes. Compared with most arboviruses, however,
WNV has been identified from an exceptionally broad
range of species. Aedes albopictus and Cx. erraticus were
recorded as the vector species for the first time in New
York State (79). After that, in North America only, the
virus has been identified in 43 different species of
mosquito. With such a broad vector range, expansion of
the geographic distribution of WNV into new areas and its
establishment seem inevitable (82).
There are an enormous number of studies carried out
in America after the first outbreak (83-92). The first
report of West Nile virus activity in Canada was in August
2001, when the virus was found in dead birds and
mosquito pools in southern Ontario and the worst
Canadian outbreak occurred in 2002 (93).
Except for a small outbreak in southern France in
1962, WNV has not been a public-health threat in
Europe. The first major West Nile Fever epidemic in
Europe occurred in Romania in 1996, with a high rate of
neurological infections (94-96). Other records came from
Ukraine (97), Croatia (98), Germany (99), Jourdan
(100), and Czechoslovakia (101).
Mosquito-borne arboviruses are also important public
health issue in Australia (102-107).
It was recorded that Israeli researchers in the 1950’s
were the first to characterize the clinical presentation of
th
WN fever, but by the end of the 20 century, WN virus
infection was an almost forgotten disease in Israel. The
vectors of WN virus in Israel were observed as Culex
species, Cx. pipiens and Cx. perexiguus (91,108,109).
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The close genetic relationship between WN virus
isolates from Israel and New York suggest that the virus
was imported into North America from the Middle East
(110), but the mode of introduction is unknown. There
are some studies on phylogenetic analysis of WNV strains
isolated from different areas (73,111,112). According to
initial nucleotide sequencing studies, strains found on the
eastern seaboard of USA were nearly identical in sequence
to the prototype New York 1999 strain. According to
some researchers there is no evidence for selection of any
phenotypic differences between isolates in North America
(82,113).
Birds are the natural reservoir hosts for WN virus,
which has been shown to infect at least 111 bird species
in North America only (73,86,114-117). In North
America, WN virus seems to be particularly virulent in
species belonging to the family Corvidae (eg.crows and
jays) (118) and these have a central role in dead-bird
based surveillance programmes for detecting and
tracking the virus (73).
Bird deaths due to WN virus are unusual outside
North America, with the exception of deaths of geese in
Israel and pigeons in Egypt (119). Whether high avian
death rates in the United States are due to higher
virulence of the circulating strains or to higher
susceptibility in North American birds requires further
evaluation (110). Then it was recorded that the unique
susceptibility of young domestic geese in Israel in 19972000 to WNV and the isolation of similar strains from
migrating White storks in Israel and Egypt suggest that
the recent isolates are more pathogenic for certain avian
species. Infected birds have recently been found in the
Caribbean and the infection will no doubt continue to
spread through the Americas (7).
Transportation of WN virus strains between different
areas by migratory viraemic birds along established
flyways is probably a common occurrence. In the eastern
hemisphere, WN virus is thought to be regularly
introduced in Mediterranean and European countries by
birds (20,120). Campbell emphasized that WN virus will
almost certainly continue to spread into the contiguous
western parts of the USA over the next years, primarily
via the movement of viraemic birds (73).
In Africa, WN virus is principally transmitted in an
enzootic cycle among Cx. univittatus and birds (121).
Many northward migratory routes follow a flyway across
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the Middle East, Turkey and the Black Sea, along which
the Danube delta is a main avian refuge (95). Regarding
this migration routes, Turkey is important place for
potential arboviruses. Up to now, there are few
seroprevalence studies showing different viruses
presence. In 916 human sera collected from Southeast
Anatolia, 40.06 % were positive for West Nile antibodies
(122). In the Aegean region of Turkey, Sindbis, West Nile
Fever, Dengue 1, CETE, Tahyna virus and Naples
prototype from Phlebotomus Fever group viruses caused
infections in the population (123).
A broad range of mammalian species are also
susceptible to natural or experimental infection with WN
virus. In the USA during 1999-2001, nine mammalian
species (human beings, horses, cats, rabbits, skunks,
squirrels, chipmunks and two species of bats) were found
to be naturally infected with WN virus. The role, if any,
that mammals play in the WN virus transmission cycle is
unknown (73,87,124).
No human vaccine for WN virus is currently available.
So, effective prevention of the disease depends on
integrated arboviral surveillance and vector mosquito
control programmes to reduce the density of vector
species, including those that might serve as a “bridge”
from birds to human beings (73,82). Cases were also of
WNV transmission transplacentally by transfusion, by
lactation, by organ transplants as new routes of
transmission (82). Werner pointed that the scope of
infectiology keeps widening, while the threat of
bioterrorism can not be neglected (125).

As seen in the above articles, without sustained vector
control in urban areas, even the world’s affluent cities are
at risk for epidemic arboviral diseases. And we do not
know how many potential organisms will share our planet
with us that are awaiting the right conditions for their
chance at stardom by becoming emerging infectious
diseases. Bearing in mind this alarming fact, new FP6
project named “Emerging Diseases in a changing
European Environment” have been already launched on
January 2005 consisting of 98 scientist in 78 institutes in
24 countries in which we take part (127). The aim of this
project, is to increase preparedness by developing and
coordinate at European level a set of generic investigation
methods, tools and skills within a common scientific
framework (Landscapes, Vector and Parasite bionomics,
Public Health, Animal Reservoirs). Some of the diseases
which are already present in Europe such as West Nile,
Rodent-borne, Tick-borne, Leishmaniasis, Bluetongue,
some were present historically such as malaria and so
may re-emerge, whilst a final group such as Plague and
Rift Valley Fever will be subject of the project. It will be
the first ever European large scale research project which
will investigate diseases from an environmentally driven
perspective. We will share the outputs of the project with
the researchers, public, national and international policy
making authorities in the next few years.
Corresponding author:
Nurdan ÖZER
Hacettepe University,
Science Faculty,
Biology Department,
06532 Beytepe, Ankara - Turkey
E-mail: nozer@hacettepe.edu.tr

In a review article by Whitehouse on Crimean-Congo
hemorrhagic fever, the recent presence of this tick-borne
disease in Turkey was recorded for the first time(126).
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